Martina Vašáková (Prague, Czech Republic), Francesco Bonella (Düsseldorf, Germany)
Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc)
Jörg Distler (Erlangen, Germany), Jingang Huang, Christian Beyer, Katrin Palumbo-Zerr, Yun Zhang, Stefan-Lutz Wollin, Jörg Distler
|  |
Expression of miR-185 targets DNA methyltransferase 1 and Cyclin D2 in IPF and lung cancer in BALF cells: Preliminary results
Eleni Bibaki (Heraklion, Crete, Greece), Eleni Bibaki, Eliza Tsitoura, Chara Koutoulaki, Eirini Vasarmidi, Evangelia Stamataki, Despina Moraitaki, Nikos Tzanakis, Katerina Antoniou
| |
Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Katrin Esther Hostettler Haack (Basel, Switzerland), Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Qingzhu Sun, Michael Tamm, Christopher Lambers, Michael Roth
| |
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro
arnaud Mailleux (Paris, France), Audrey Joannes, Joëlle Marchal-Somme, Bruno Crestani, Arnaud Mailleux
| |
Real life patient experience of pirfenidone in a regional interstitial lung disease clinic
Abirami Subramaniam (Dublin, Ireland), Abirami Subramaniam, Mohamed Elshafi, Loraine Thong, Kate O’Halloran, Bernadette Bowen, Kashif Khan, Desmond Murphy, Barry Plant, Marcus Kennedy, Michael Henry
|  |
Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Dirk Steffen Koschel (Radebeul, Germany), Lars Lützkendorf, Marcus Vogler, Gert Höffken, Dirk Koschel
| |
Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
Claudia Valenzuela (Alcobendas (Madrid), Spain), Claudia Valenzuela, Maria Molina, Fátima Diaz Chantar, Tamara Alonso, Jose Antonio Rodriguez Portal, Maria Jesus Rodriguez Nieto, Rosalia Laporta, María Jesús Linares, Julio Ancochea
| |
Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis
Paola Faverio (Limbiate, Italy), Paola Faverio, Roberto Ruggiero, Valentina Paolini, Luca Novelli, Federica De Giacomi, Alice Biffi, Elisa Oggionni, Luca Bilucaglia, Alberto Pesci
| |
Inhaled PHMG can induce pulmonary fibrosis through mitochondrial ROS generation
So Ri Kim (Jeonju, Republic of Korea), So Ri Kim, Yong Chul Lee, Dong Im Kim, Hae Jin Park, Soon Ha Kim
| |
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Nour Bacha (Gournay-Sur-Marne, France), Nour Bacha, Adeline Blandinières, Pascale Gaussem, Chantal Boulanger, Jean Marie Renard, Eduardo Anglès-Cano, Dominique Israël-Biet, David Smadja
| |
FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice
Aurelien Justet (Paris, France), Aurélien Justet, Audrey Joannes, Joelle Marchal-Somme, Valérie Besnard, Philippe Bonniaud, Arnaud Mailleux, Bruno Crestani
| |
Role of the nitric oxide-asymmetric dimethylarginine-dimethylarginine dimethylaminohydrolase (NO-ADMA-DDAH) axis in TGF-β mediated epithelial-mesenchymal transition
Harpreet Lota (Hounslow, United Kingdom), Harpreet K. Lota, James M. Leiper
| |
Etablishing rhesus model of pulmonary fibrosis (PF) for the new drug evaluation
Lian Liu (Chengdu, China), Lian Liu, Hao Wang, Hao Wang, Xiaoou Li, Fuqiang Wen
| |
Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis
Ming Liu (Guangzhou, China), Ming Liu
| |
Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Katrin Esther Hostettler Haack (Basel, Switzerland), Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Michael Tamm, Christopher Lambers, Didier Lardinois, Michael Roth
| |
Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis
Nicolas Kahn (Heidelberg, Germany), Nicolas Kahn, Martin Granzow, Michael Meister, Ralf Eberhardt, Thomas Muley, Eva Baroke, Ute Oltmanns, Felix J.F. Herth, Michael Kreuter
| |
Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD)
Xiaoping Long (Essen, Germany), Xiaoping Long, Ulrich Costabel, Xuan He, Thomas E. Wessendorf, Dirk Theegarten, Josune Guzman, Francesco Bonella
| |
Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis
Katrin Esther Hostettler Haack (Basel, Switzerland), Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Chistopher Lambers, Michael Tamm, Michael Roth
| |